OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aducanumab for the treatment of Alzheimer's disease: a systematic review
Afroza Rahman, Md. Anwar Hossen, Mirza Farhana Iqbal Chowdhury, et al.
Psychogeriatrics (2023) Vol. 23, Iss. 3, pp. 512-522
Open Access | Times Cited: 58
Afroza Rahman, Md. Anwar Hossen, Mirza Farhana Iqbal Chowdhury, et al.
Psychogeriatrics (2023) Vol. 23, Iss. 3, pp. 512-522
Open Access | Times Cited: 58
Showing 26-50 of 58 citing articles:
Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
Thomas Gabriel Schreiner, Cristina Croitoru, Diana Nicoleta Hodorog, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 2
Thomas Gabriel Schreiner, Cristina Croitoru, Diana Nicoleta Hodorog, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 2
Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline
Ali Azargoonjahromi
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 9, pp. 1115-1131
Closed Access | Times Cited: 2
Ali Azargoonjahromi
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 9, pp. 1115-1131
Closed Access | Times Cited: 2
Aducanumab: una mirada dos años después de su aprobación
Astrid Torres, Loida Camargo, Norman López
Biomédica (2024) Vol. 44, Iss. Sp. 1, pp. 42-46
Open Access | Times Cited: 2
Astrid Torres, Loida Camargo, Norman López
Biomédica (2024) Vol. 44, Iss. Sp. 1, pp. 42-46
Open Access | Times Cited: 2
The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer’s disease
Antero Salminen
Journal of Molecular Medicine (2024)
Open Access | Times Cited: 2
Antero Salminen
Journal of Molecular Medicine (2024)
Open Access | Times Cited: 2
Big versus small: The impact of aggregate size in disease
Brianna Hnath, Jiaxing Chen, Joshua Reynolds, et al.
Protein Science (2023) Vol. 32, Iss. 7
Open Access | Times Cited: 6
Brianna Hnath, Jiaxing Chen, Joshua Reynolds, et al.
Protein Science (2023) Vol. 32, Iss. 7
Open Access | Times Cited: 6
Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer’s Disease Based on Novel Monoterpene-Derived Hydroxamic Acids
Yulia Aleksandrova, Aldar A. Munkuev, Evgenii S. Mozhaitsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9743-9743
Open Access | Times Cited: 5
Yulia Aleksandrova, Aldar A. Munkuev, Evgenii S. Mozhaitsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9743-9743
Open Access | Times Cited: 5
Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease
Aline Freyssin, Allison Carles, Sarra Guehairia, et al.
Neuropharmacology (2023) Vol. 242, pp. 109733-109733
Open Access | Times Cited: 4
Aline Freyssin, Allison Carles, Sarra Guehairia, et al.
Neuropharmacology (2023) Vol. 242, pp. 109733-109733
Open Access | Times Cited: 4
Analyzing public discourse of dementia from Spanish and English tweets: a comparative analysis with other neurological disorders
Javier Domingo-Espiñeira, Oscar Fraile‐Martínez, Cielo García‐Montero, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Javier Domingo-Espiñeira, Oscar Fraile‐Martínez, Cielo García‐Montero, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
The gamma rhythm as a guardian of brain health
Ana Maria Ichim, Harald Bârzan, Vasile V. Moca, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Ana Maria Ichim, Harald Bârzan, Vasile V. Moca, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
A versatile fabrication route for screening block copolymer membranes for bioprocessing
Ke Meng, Alberto Álvarez‐Fernández, Stefan Guldin, et al.
(2024)
Open Access | Times Cited: 1
Ke Meng, Alberto Álvarez‐Fernández, Stefan Guldin, et al.
(2024)
Open Access | Times Cited: 1
AR71, Histamine H3 Receptor Ligand—In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action)
Anna Stasiak, Ewelina Honkisz-Orzechowska, Z Gajda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8035-8035
Open Access | Times Cited: 1
Anna Stasiak, Ewelina Honkisz-Orzechowska, Z Gajda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8035-8035
Open Access | Times Cited: 1
CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer’s Disease Treatment: A Systematic Review of Available Clinical Data
Premrutai Thitilertdecha, James Michael Brimson
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S115-S128
Closed Access | Times Cited: 1
Premrutai Thitilertdecha, James Michael Brimson
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S115-S128
Closed Access | Times Cited: 1
Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application
J. Nandhini, Karthikeyan Elumalai
Chronic Diseases and Translational Medicine (2024)
Open Access | Times Cited: 1
J. Nandhini, Karthikeyan Elumalai
Chronic Diseases and Translational Medicine (2024)
Open Access | Times Cited: 1
Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment
Jeffrey N. Motter, Sara N. Rushia, Min Qian, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Closed Access | Times Cited: 2
Jeffrey N. Motter, Sara N. Rushia, Min Qian, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Closed Access | Times Cited: 2
Drug Design for Alzheimer’s Disease: Biologics vs. Small Molecules
Donald F. Weaver
Current Alzheimer Research (2023) Vol. 20, Iss. 12, pp. 821-826
Closed Access | Times Cited: 2
Donald F. Weaver
Current Alzheimer Research (2023) Vol. 20, Iss. 12, pp. 821-826
Closed Access | Times Cited: 2
A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease
Álvaro Esteban Martos, Ana María Brokate-Llanos, Luís Miguel Real, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12079-12079
Open Access | Times Cited: 2
Álvaro Esteban Martos, Ana María Brokate-Llanos, Luís Miguel Real, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12079-12079
Open Access | Times Cited: 2
Alzheimer's disease - a review of medicinal substances and their derivatives
Marika Więcek, Dorota G. Piotrowska, Michał Kołodziejczyk, et al.
Farmacja Polska (2024) Vol. 79, Iss. 12, pp. 789-800
Open Access
Marika Więcek, Dorota G. Piotrowska, Michał Kołodziejczyk, et al.
Farmacja Polska (2024) Vol. 79, Iss. 12, pp. 789-800
Open Access
The MET growth signaling complex drives Alzheimer’s Disease-associated brain pathology in aged Shugoshin 1 mouse cohesinopathy model
Chinthalapally V. Rao, Julie Crane, Ben Fowler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Chinthalapally V. Rao, Julie Crane, Ben Fowler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Decoding green food safety information dependency in the digital era: An intelligent validation using SEM-ANN framework
Tong Zhao, Qiumei Shi, X.S. Zhang, et al.
Journal of Retailing and Consumer Services (2024) Vol. 79, pp. 103886-103886
Closed Access
Tong Zhao, Qiumei Shi, X.S. Zhang, et al.
Journal of Retailing and Consumer Services (2024) Vol. 79, pp. 103886-103886
Closed Access
Revisiting capsaicin and nonivamide: Their analogs exert strong inhibitory activity against cholinesterases
Niels V. Heise, Jeremy Quast, René Csük
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100200-100200
Open Access
Niels V. Heise, Jeremy Quast, René Csük
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100200-100200
Open Access
Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's Disease
Jiale Ren, Beibei Xiang, Lin Xueling, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36470-e36470
Open Access
Jiale Ren, Beibei Xiang, Lin Xueling, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36470-e36470
Open Access
Que sait-on de la mémantine comme traitement de la maladie d’Alzheimer en 2024 ?
Bruno Oquendo, Victoria Zolnowski‐Kolp, Joël Belmin
NPG. Neurologie, psychiatrie, gériatrie/NPG (2024)
Closed Access
Bruno Oquendo, Victoria Zolnowski‐Kolp, Joël Belmin
NPG. Neurologie, psychiatrie, gériatrie/NPG (2024)
Closed Access
Repurposing of USFDA-approved drugs to identify lead for inhibition of acetylcholinesterase enzyme: A plausible utility as an anti-Alzheimer agent
Kapil Kumar Goel, Sandhya Chahal, Devendra Kumar, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Kapil Kumar Goel, Sandhya Chahal, Devendra Kumar, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Eplingiella fruticosa leaf essential oil complexed with β-cyclodextrin exerts a neuroprotective effect in an Alzheimer’s disease animal model induced by Streptozotocin
Vanessa Alexandre-Silva, Beatriz Soares‐Silva, Gabrielle Christine Pereira, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access
Vanessa Alexandre-Silva, Beatriz Soares‐Silva, Gabrielle Christine Pereira, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access
Bioimaging of Neuroimmune Disorders: Physical Principles of Neuroimaging Modalities and Clinical Applications
Mahsa Mayeli, Thomas Ernst, Linda Chang
NeuroImmune Pharmacology and Therapeutics (2024), pp. 807-830
Closed Access
Mahsa Mayeli, Thomas Ernst, Linda Chang
NeuroImmune Pharmacology and Therapeutics (2024), pp. 807-830
Closed Access
